Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 18 Aug 2026. Factsheet Jun 2026. About · Disclosures
Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth
Whiteoak Capital Mutual FundSectoral Pharma and HealthcareDirectGrowth
NAV
₹17.579
As on 18 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +21.86% | — | — |
| 3 year | +24.98% | — | — |
| 5 year | +24.98% | — | — |
All Sectoral Pharma and Healthcare funds · Whiteoak Capital Mutual Fund
Returns
From NAVs through 18 Aug 2026
1Y
+21.86%
Total
3Y
+24.98%
p.a.
5Y
+24.98%
p.a.
SI
+24.98%
p.a.
Calendar years
+39.42%2024
+1.84%2025
+23.80%2026 YTD
Rolling 1-year · 18 overlapping windows
+2.68%avg +17.03%+30.89%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹664.02 Cr
Expense ratio
0.60%
Exit load
None
Lock-in
None
Launched06 Feb 2024
StructureOpen Ended
ISININF03VN01886
Where the money is invested
Split by asset type.
By asset type
Equity99.08%
Cash0.92%
What the fund holds
62 holdings · portfolio as on 30 May 2026
- 9.56%Sun Pharmaceuticals Industries LtdHealthcare
- 6.8%J.B. Chemicals & Pharmaceuticals LtdHealthcare
- 4.83%Apollo Hospitals Enterprise LtdHealthcare
- 4.43%Laurus Labs LtdHealthcare
- 3.94%Clearing Corporation of India Ltd
- 3.92%Fortis Healthcare LtdHealthcare
- 3.44%Krishna Institute of Medical Sciences LtdHealthcare
- 3.29%Divi's Laboratories LtdHealthcare
- 3.17%Sai Life Sciences LtdHealthcare
- 2.83%Max Healthcare Institute Ltd Ordinary SharesHealthcare
Concentration
Top 5 weight
29.56%
Top 10 weight
46.21%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
0.88
Better than category avg 0.48
Alpha
7.47
Return above the benchmark
Risk
Std deviation
15.78%
How much returns swing
Beta
1
Below category avg 0.94
R-squared
96.5%
How closely it tracks the benchmark
Who manages this fund
4 fund managers
- PBPiyush Baranwal11.4 years in the industryRuns 25 schemes
- TATrupti Agrawal3.5 years in the industryRuns 17 schemes
- AAAshish Agrawal1.5 years in the industryRuns 18 schemes
- RMRamesh Mantri3.9 years in the industryRuns 18 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+24.98%
Invested
₹6,00,000
Illustrated
₹26,60,610
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- regularGrowthWhiteoak Capital Pharma and Healthcare Fund - Regular Plan - GrowthNAV ₹14.19
FAQ
What is Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth NAV today?
- The latest NAV of Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth is ₹17.579 as on 18 Aug 2026.
How has Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth performed vs its category?
- 1-year return +21.86%. Past performance does not guarantee future returns.
What are the returns of Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
- Trailing returns from published NAVs: 1 year +21.86%, 3 year +24.98% a year, 5 year +24.98% a year, since our first NAV +24.98% a year. Past performance does not guarantee future returns.
How would a SIP in Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +24.98%. It is not a forecast.
What is the expense ratio and fund size of Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
- For Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth, the expense ratio is 0.60% and fund size (AUM) is ₹664.02 Cr.
What is the ISIN of Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth?
- The ISIN for Whiteoak Capital Pharma and Healthcare Fund - Direct Plan - Growth is INF03VN01886.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.